Inadequate TPMT activity results in excessive accumulation of the active TGN, leading to dose-dependent marrow suppression and a risk of infection, whereas NUDT15 variants are associated with severe early-onset leukopenia, gastrointestinal toxicity, and alopecia even at moderate doses. This evidence concerns the gene NUDT15 and Decreased total leukocyte count.